Hussain M, Corcoran C, Sibilla C, Fizazi K, et al. Tumor Genomic Testing for >4000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib). Clin Cancer Res 2022 Jan 28. pii: 1078-0432.CCR-21-3940.
PMID: 35091440